Clinical Trial

Effects of Mulberry Leaf Extract Formulation on Postprandial Glycemic Levels in Obese Children and Adolescents

Study acronym: PEDRED
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The study entitled "Effects of mulberry leaf extract formulationon Postprandial Glycemic Peak in Obese Children and Adolescents: A Pilot Study" aims to evaluate the improvement in glycemic and insulinemic levels produced by a food supplement extracted from white mulberry (Morus alba), after 12 weeks of treatment in a cohort of obese children and adolescents. Clinical and anthropometric data (age, sex, weight, height, BMI, pubertal stage) will be collected, along with data from blood chemistry tests performed during routine follow-up visits, in accordance with Good Clinical Practice guidelines.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2026-03-19; most recent amendment 2026-06-17.
Trial Details
NCT Number NCT07494253
Lead Sponsor University of Bari Aldo Moro
Conditions Obesity
Enrollment 80 participants
Start Date 2025-06-01
Primary Completion 2026-01-12 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-22